Endonovo Therapeutics Provides SofPulse® To All NFL Teams
December 23, 2019 08:30 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today the delivery of SofPulse® evaluation units to all...
Endonovo Therapeutics Announces Effective Date of Previously Announced Reverse Split of Common Stock
December 19, 2019 18:24 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today that its previously announced 1-for-1,000 reverse split of...
Endonovo Therapeutics Announces Reverse Stock Split - UPDATE
December 11, 2019 13:40 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock...
Endonovo Therapeutics Announces Reverse Stock Split
December 11, 2019 12:47 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today it has determined to effect a 1-for-1,000 reverse stock...
Endonovo Therapeutics Reports Third Quarter 2019 Results
November 19, 2019 16:35 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today its financial results for the quarter ended September 30,...
Endonovo Therapeutics Announces Reverse Stock Split
October 31, 2019 12:43 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced that it had filed a preliminary information statement...
Endonovo Therapeutics Appoints Dr. William Li as Strategic Advisor to the CEO
September 30, 2019 09:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces it has appointed Dr. William Li as Strategic Advisor to...
Endonovo Therapeutics and Veterans Healthcare Supply Solutions Announce Distribution Agreement
May 21, 2019 09:20 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, May 21, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) and Veterans Healthcare Supply Solutions Inc. (VHSS) today announced a long-term agreement encompassing...
Endonovo Therapeutics Appoints Dr. Roc Alan McCarthy as a Scientific Advisory Board Member
May 09, 2019 09:20 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA , May 09, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, that Roc Alan McCarthy, D.O. will be joining the company as a Scientific Advisory Board...
Endonovo Therapeutics Announces Steven Ford as V.P. Marketing
May 07, 2019 09:20 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, May 07, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced, Steven Ford will be joining the company as Vice President of Marketing. In his position,...